ATE284222T1 - Modifizierte proteine und deren verwendung zur kontrolle von virusinfektionen - Google Patents

Modifizierte proteine und deren verwendung zur kontrolle von virusinfektionen

Info

Publication number
ATE284222T1
ATE284222T1 AT92906661T AT92906661T ATE284222T1 AT E284222 T1 ATE284222 T1 AT E284222T1 AT 92906661 T AT92906661 T AT 92906661T AT 92906661 T AT92906661 T AT 92906661T AT E284222 T1 ATE284222 T1 AT E284222T1
Authority
AT
Austria
Prior art keywords
modified proteins
functional groups
polypeptides
basic
amino acids
Prior art date
Application number
AT92906661T
Other languages
English (en)
Inventor
Robert Walter Jansen
Dirk Klaas Fokke Meijer
Grietje Molema
Clercq Erik Desire Alice De
Rudi Wilfried Jan Pauwels
Dominique Schols
Original Assignee
Univ Groningen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Groningen filed Critical Univ Groningen
Application granted granted Critical
Publication of ATE284222T1 publication Critical patent/ATE284222T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92906661T 1991-03-11 1992-02-24 Modifizierte proteine und deren verwendung zur kontrolle von virusinfektionen ATE284222T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9100434A NL9100434A (nl) 1991-03-11 1991-03-11 Farmaceutische preparaten voor de bestrijding van virale infecties en immuundeficientieziekten, de bereiding en toepassing daarvan.
PCT/NL1992/000036 WO1992015316A1 (en) 1991-03-11 1992-02-24 Modified proteins and their use for controlling viral infections

Publications (1)

Publication Number Publication Date
ATE284222T1 true ATE284222T1 (de) 2004-12-15

Family

ID=19859005

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92906661T ATE284222T1 (de) 1991-03-11 1992-02-24 Modifizierte proteine und deren verwendung zur kontrolle von virusinfektionen

Country Status (9)

Country Link
EP (1) EP0575432B1 (de)
JP (1) JP2690813B2 (de)
AT (1) ATE284222T1 (de)
AU (1) AU1566392A (de)
DE (1) DE69233455T2 (de)
DK (1) DK0575432T3 (de)
ES (1) ES2233923T3 (de)
NL (1) NL9100434A (de)
WO (1) WO1992015316A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010799A1 (en) * 1991-11-27 1993-06-10 Immtech International Incorporated Method of treating viral infections
US5405832A (en) * 1991-11-27 1995-04-11 Immtech International Inc. Method of treating non-streptococcal bacterial infections
WO1995005455A1 (en) * 1993-08-13 1995-02-23 Rijksuniversiteit Te Groningen Pharmaceutical composition comprising phosphatase or a derivative thereof
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
US5985275A (en) * 1995-04-12 1999-11-16 New York Blood Center β-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infection
AU1707197A (en) * 1996-03-20 1997-10-10 New York Blood Center, Inc., The Methods of treating herpes or chlamydia
US5952009A (en) * 1996-03-20 1999-09-14 New York Blood Center Methods for preventing the transmission of or treating patients infected with herpesvirus
EP1426382A1 (de) * 2002-12-06 2004-06-09 Aventis Behring GmbH Antivirales menschliches Serum Albumin
WO2004100966A1 (ja) 2003-05-16 2004-11-25 Bbk Bio Corporation 病態起因物質の生体への接触防止用製剤
FR2862134B1 (fr) 2003-11-12 2007-07-27 Sebia Sa Analyse et typage de proteines monoclonales par electrophorese capillaire et immunodeplacement
CN109675042B (zh) * 2019-02-01 2021-03-23 山西锦波生物医药股份有限公司 用于治疗和/或预防流感的组合物、方法和用途
RU2716003C1 (ru) * 2019-09-09 2020-03-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова) Применение сывороточного альбумина в качестве противомикробного агента

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2696379B2 (ja) * 1989-01-09 1998-01-14 明治乳業株式会社 抗ｈｉｖ剤
EP0406416B1 (de) * 1989-01-09 1994-01-19 Meiji Milk Products Company Limited Anti-hiv-mittel

Also Published As

Publication number Publication date
WO1992015316A1 (en) 1992-09-17
JPH06505264A (ja) 1994-06-16
JP2690813B2 (ja) 1997-12-17
AU1566392A (en) 1992-10-06
NL9100434A (nl) 1992-10-01
DE69233455D1 (de) 2005-01-13
ES2233923T3 (es) 2005-06-16
DE69233455T2 (de) 2005-12-22
EP0575432A1 (de) 1993-12-29
EP0575432B1 (de) 2004-12-08
HK1010684A1 (en) 1999-06-25
DK0575432T3 (en) 2005-04-04

Similar Documents

Publication Publication Date Title
ATE284222T1 (de) Modifizierte proteine und deren verwendung zur kontrolle von virusinfektionen
Cleveland et al. Conservation of microtubule associated proteins. Isolation and characterization of tau and the high molecular weight microtubule associated protein from chicken brain and from mouse fibroblasts and comparison to the corresponding mammalian brain proteins
ATE133449T1 (de) Infektiöses system zur arzneimittelabgabe
EP0158277A3 (de) Implantierbare Zubereitungen von regulatorischen Peptiden mit gesteuerter Freisetzung und Verfahren zur ihrer Herstellung
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
ATE383424T1 (de) Polypeptide, deren herstellung und verwendung
DK163683D0 (da) Fremstilling af funktionelle humane urokinaseproteiner, dna-sekvens, der koder for et protein omfattende den enzymatiske del af human urokinase, replicerbart udtrykkelsesmedium, der kan udtrykkedna-sekvensen og mikroorganisme eller cellekultur transformeret med mediet
ATE171471T1 (de) Isolierte virale proteine als cytokinantagonisten
ATE451835T1 (de) Therapeutische verfahren und zusammensetzungen unter verwendung von viren der rekombinanten familie der paramyxoviridae
BR0012919A (pt) Vacina para uso na profilaxia e/ou no tratamento da sìndrome de ponto branco (white spot syndrome) em crustáceos, proteìna estrutural derivada do vìrus da sìndrome de ponto branco, sequência de ácido nucléico, uso de uma proteìna estrutural, composição farmacêutica, anticorpos, vacina ou formulação farmacêutica, e, kit diagnóstico para detecção de wssv
ATE89735T1 (de) Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.
ATE175119T1 (de) Vakzine gegen immunodefizienz-virus der katze (kiv)
BR9106159A (pt) Polipeptideo sintetico,vacina,estojo para detectar hiv ou anticorpos contra hiv,molecula de dna,composicao farmaceutica,anticorpo ou fragmento de ligacao de antigeno do mesmo,processos de terapia ou profilaxia de infeccao hiv,de detectar hiv,de diagnosticar infeccao hiv e para a manufatura de um polipeptideo sintetico,de uma composicao farmaceutica e de um anticorpo ou fragmento de ligacao do mesmo
DK476688A (da) Hiv-proteiner og -peptider, der er nyttige ved aids-diagnose, -profylakse og -terapi
DE69836758D1 (de) Apo b, annexin v und tubulin: medizinische und diagnostische verwendung und verwendung zur purifikation von hcv
DE3788852D1 (de) Proteine mit Glutathion-S-Transferase-Aktivität, DNA-Sequenzen, Antikörper, Poxviren und Arzneimittel zur Prävention von Schistosomiasis.
ES2044881T3 (es) Procedimiento para la preparacion de una fosfoproteina estructural (pp 150) del citomegalovirus humano.
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
NO172537C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-desmetyl-4-fluor-mevalonsyrederivater
DK0653939T3 (da) Anvendelse af en Hymenoptera-gift til fremstilling af et medikament til behandling af DNA-virusinfektioner
ES2149822T3 (es) Peptidos inmunorreactivos procedentes del virus de epstein-barr.
ATE208421T1 (de) Stimulierung der immunantwort durch virales protein
EP0311228A3 (de) Rekombinante Polypeptide und ihre Verwendung einschliesslich Nachweisverfahren für AIDS-Virus
ATE358727T1 (de) Rekombinante bifunktionale fusionsproteine zur abtreibung variabler viren
DE69126977D1 (de) Verwendung von Leukoregulin zur Behandlung von mit einem envelope-Virus infizierten Tier

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0575432

Country of ref document: EP

REN Ceased due to non-payment of the annual fee